Cargando…

miR-338-3p Plays a Significant Role in Casticin-Induced Suppression of Acute Myeloid Leukemia via Targeting PI3K/Akt Pathway

OBJECTIVE: Casticin is generally used in traditional herbal medicine for its anti-inflammatory and anticarcinogenic pharmacological properties. Also, microRNAs are indispensable oncogenes or cancer suppressors being dysregulated in various diseases. In this study, we aimed to elucidate the mechanism...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Kewei, Wang, Juan, Hou, Junhui, Zhang, Lei, Liang, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233736/ https://www.ncbi.nlm.nih.gov/pubmed/35765408 http://dx.doi.org/10.1155/2022/9214130

Ejemplares similares

Casticin inhibits breast cancer cell migration and invasion by down-regulation of PI3K/Akt signaling pathway
por: Fan, Li, et al.
Publicado: (2018)

Expression of Concern: Casticin inhibits breast cancer cell migration and invasion by downregulation of PI3K/Akt signaling pathway
Publicado: (2021)

Casticin inhibits nasopharyngeal carcinoma growth by targeting phosphoinositide 3-kinase
por: Liu, Jingxian, et al.
Publicado: (2019)

Correction to: Casticin inhibits nasopharyngeal carcinoma growth by targeting phosphoinositide 3-kinase
por: Liu, Jingxian, et al.
Publicado: (2021)

An Overview of the Potential Antineoplastic Effects of Casticin
por: Ramchandani, Shanaya, et al.
Publicado: (2020)

SPRR3, a novel miR-338-3p target, regulates the malignant progression of clear cell renal cell carcinoma in vitro via the PI3K/Akt signaling pathway
por: Wu, Man, et al.
Publicado: (2022)

The PI3K-Akt-mTOR Signaling Pathway in Human Acute Myeloid Leukemia (AML) Cells
por: Nepstad, Ina, et al.
Publicado: (2020)

TUC338 Promotes Diffuse Large B Cell Lymphoma Growth via Regulating EGFR/PI3K/AKT Signaling Pathway
por: Li, Yan, et al.
Publicado: (2021)

MiR-338-3p regulates neuronal maturation and suppresses glioblastoma proliferation
por: Howe, James R., et al.
Publicado: (2017)

MiR-338-3p improved lung adenocarcinoma by AKAP12 suppression
por: Chang, Jin, et al.
Publicado: (2019)

Long non-coding RNA NEAT1/miR-338-3p axis impedes the progression of acute myeloid leukemia via regulating CREBRF
por: Feng, Song, et al.
Publicado: (2020)

A Circ-0007022/miR-338-3p/Neuropilin-1 Axis Reduces the Radiosensitivity of Esophageal Squamous Cell Carcinoma by Activating Epithelial-To-Mesenchymal Transition and PI3K/AKT Pathway
por: Zhang, Junpeng, et al.
Publicado: (2022)

CircRNA RNA hsa_circ_0008234 Promotes Colon Cancer Progression by Regulating the miR-338-3p/ETS1 Axis and PI3K/AKT/mTOR Signaling
por: Wu, Dejun, et al.
Publicado: (2023)

miR-338-3p suppresses the malignancy of T-cell lymphoblastic lymphoma by downregulating HOXA3
por: Wang, Li, et al.
Publicado: (2019)

Casticin inhibits interleukin-1β–induced ICAM-1 and MUC5AC expression by blocking NF-κB, PI3K-Akt, and MAPK signaling in human lung epithelial cells
por: Liou, Chian-Jiun, et al.
Publicado: (2017)

Arbutin suppresses osteosarcoma progression via miR‐338‐3p/MTHFD1L and inactivation of the AKT/mTOR pathway
por: Wang, Cheng‐Qun, et al.
Publicado: (2020)

The PI3K/AKT Pathway Inhibitor ISC-4 Induces Apoptosis and Inhibits Growth of Leukemia in Preclinical Models of Acute Myeloid Leukemia
por: Annageldiyev, Charyguly, et al.
Publicado: (2020)

PTEN Regulates BCRP/ABCG2 and the Side Population through the PI3K/Akt Pathway in Chronic Myeloid Leukemia
por: Huang, Fang-Fang, et al.
Publicado: (2014)

Matrine induces apoptosis in acute myeloid leukemia cells by inhibiting the PI3K/Akt/mTOR signaling pathway
por: Hao, Yanmei, et al.
Publicado: (2019)

Effects of insulin and pathway inhibitors on the PI3K-Akt-mTOR phosphorylation profile in acute myeloid leukemia cells
por: Nepstad, Ina, et al.
Publicado: (2019)

Downregulation of SMIM3 inhibits growth of leukemia via PI3K-AKT signaling pathway and correlates with prognosis of adult acute myeloid leukemia with normal karyotype
por: Liu, Yu, et al.
Publicado: (2022)

Outlook on PI3K/AKT/mTOR inhibition in acute leukemia
por: Fransecky, Lars, et al.
Publicado: (2015)

Correction: PTEN Regulates BCRP/ABCG2 and the Side Population through the PI3K/Akt Pathway in Chronic Myeloid Leukemia
Publicado: (2014)

Targeting the PI3K/AKT pathway via GLI1 inhibition enhanced the drug sensitivity of acute myeloid leukemia cells
por: Liang, Hui, et al.
Publicado: (2017)

Withanolide Metabolites Inhibit PI3K/AKT and MAPK Pro-Survival Pathways and Induce Apoptosis in Acute Myeloid Leukemia Cells
por: Akhtar, Nosheen, et al.
Publicado: (2020)

PD-L1 regulates cell proliferation and apoptosis in acute myeloid leukemia by activating PI3K-AKT signaling pathway
por: Wang, Fang, et al.
Publicado: (2022)

The effects of casticin and myricetin on liver damage induced by methotrexate in rats
por: Eki̇nci̇-Akdemi̇r, Fazile Nur, et al.
Publicado: (2018)

c-Myc suppresses miR-451⊣YWTAZ/AKT axis via recruiting HDAC3 in acute myeloid leukemia
por: Su, Rui, et al.
Publicado: (2016)

Casticin-Induced Inhibition of Cell Growth and Survival Are Mediated through the Dual Modulation of Akt/mTOR Signaling Cascade
por: Lee, Jong Hyun, et al.
Publicado: (2019)

miR-181d promotes cell proliferation via the IGF1/PI3K/AKT axis in glioma
por: Tang, Dong, et al.
Publicado: (2020)

Casticin suppresses RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating the AKT/ERK and NF-κB signaling pathways
por: Yang, Fan, et al.
Publicado: (2023)

Ovatodiolide targets chronic myeloid leukemia stem cells by epigenetically upregulating hsa-miR-155, suppressing the BCR-ABL fusion gene and dysregulating the PI3K/AKT/mTOR pathway
por: Tu, Yue-Xing, et al.
Publicado: (2017)

GLI1 reduces drug sensitivity by regulating cell cycle through PI3K/AKT/GSK3/CDK pathway in acute myeloid leukemia
por: Zhou, Cheng, et al.
Publicado: (2021)

PI3K/AKT/PTEN Signaling as a Molecular Target in Leukemia Angiogenesis
por: Okumura, Naoko, et al.
Publicado: (2012)

Interferon regulatory factor 3 plays an anti-inflammatory role in microglia by activating the PI3K/Akt pathway
por: Tarassishin, Leonid, et al.
Publicado: (2011)

miR-338-3p suppresses tumor growth of ovarian epithelial carcinoma by targeting Runx2
por: Wen, Chunyan, et al.
Publicado: (2021)

Induction of Multidrug Resistance of Acute Myeloid Leukemia Cells by Cocultured Stromal Cells via Upregulation of the PI3K/Akt Signaling Pathway
por: Chen, Ping, et al.
Publicado: (2016)

ROS play an important role in ATPR inducing differentiation and inhibiting proliferation of leukemia cells by regulating the PTEN/PI3K/AKT signaling pathway
por: Feng, Yubin, et al.
Publicado: (2019)

Casticin as potential anticancer agent: recent advancements in multi-mechanistic approaches
por: Carbone, Katya, et al.
Publicado: (2023)

Thymoquinone Inhibits JAK/STAT and PI3K/Akt/ mTOR Signaling Pathways in MV4-11 and K562 Myeloid Leukemia Cells
por: Al-Rawashde, Futoon Abedrabbu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r1h5j4nl31hji7g5s8oli4c3ok